UroGen Pharma
URGN
URGN
172 hedge funds and large institutions have $835M invested in UroGen Pharma in 2026 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 52 increasing their positions, 47 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
1.97% more ownership
Funds ownership: 93.38% → 95.36% (+2%)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
18% less capital invested
Capital invested by funds: $1.02B → $835M (-$189M)
Holders
172
Holding in Top 10
4
Calls
$4.26M
Puts
$3.83M
Top Buyers
| 1 | +$52.5M | |
| 2 | +$45.1M | |
| 3 | +$23.3M | |
| 4 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$11.6M |
| 5 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
+$10.7M |
Top Sellers
| 1 | -$55.5M | |
| 2 | -$14.8M | |
| 3 | -$11.8M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$9.42M |
| 5 |
SCM
Superstring Capital Management
New York
|
-$6.64M |
